Mass Mortality of Sea Lions Caused by Highly Pathogenic Avian Influenza A(H5N1) Virus
Massive mortality of 5,224 sea lions (Otaria flavescens) in Peru seems to be associated with highly pathogenic avian influenza A(H5N1) virus infection.
News
Scientific Papers
Article
Assessing the health burden of vaccine-preventable infections in European adults: challenges and opportunities translated into action
Accurate information on the health burden of vaccine-preventable infections (VPIs) is needed to support evidence-informed vaccine policy recommendations and programmes in Europe.
News
Policy & Recommendations
COP28: climate crisis is a health crisis, say scientific and health-focused organisations and experts
ESWI endorses a joint statement initiated by ERS and ELF to prioritise action to mitigate but also adapt to the health effects of climate change, to prepare societies and communities for a much more complex future.
Article
News
Scientific Papers
The Adult Immunization Board (AIB): A new platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in Europe
People can be at risk of getting and spreading serious vaccine-preventable infectious diseases throughout their lives and can therefore benefit from a lifelong approach to vaccination.
PROGRAMMING survey on educational needs in the care of older people
The COST Action Promoting geriatric medicine in countries where it is still emerging (PROGRAMMING) has launched a survey aiming to map the educational interests and needs of current and future healthcare professionals in the field of care for older people
Sequential vaccinations with divergent H1N1influenza virus strains induce multi-H1 cladeneutralizing antibodies in swine
Vaccines that protect against any H1N1 influenza A virus strain would beadvantageous for use in pigs and humans.
Facts and fallacies about vaccination by the Dutch Influenza Foundation
An independent information document for nurses
Australian vaccination warning as flu lingers into summer 2023/24
Winter may be long gone and summer just around the corner, but the flu season is dragging on with all states continuing to record cases.
RSV IMMUNISATION FOR INFANTS IN EUROPE: ARE OUR HEALTH SYSTEMS READY?
EHMA publishes a paper based on expert insight from across Europe, exploring the challenges and opportunities of implementing RSV immunisation programmes in different country contexts.
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired pneumonia as the major disease-related burden.
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
|
ESWI Airborne: Immunisation & Treatment
Immunisation & Treatment - Societal benefits of immunising children
Is there a difference between recommending flu, RSV and COVID-19 vaccinations in children? What is meant by preventing secondary diseases and other societal wider benefits? ...